Cationic nanocarriers: A potential approach for targeting negatively charged cancer cell

M Vishwakarma, P Agrawal, S Soni, S Tomar… - Advances in Colloid and …, 2024 - Elsevier
Cancer, a widespread and lethal disease, necessitates precise therapeutic interventions to
mitigate its devastating impact. While conventional chemotherapy remains a cornerstone of …

Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors

J Wang, Y Ma, H Lin, J Wang, B Cao - BMC immunology, 2024 - Springer
Purpose The objective of this study was to identify potential predictors of immune-related
adverse events (irAEs) in cancer patients receiving immune checkpoint inhibitor therapy …

Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor …

KK Chan, AR Bass - Rheumatic Disease Clinics, 2024 - rheumatic.theclinics.com
The introduction of immune checkpoint inhibitors (ICIs) to treat malignancies has led to a
tremendous gain in cancer survival for many different types of cancer. However, along with …

Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022

M Yanagita, S Muto, H Nishiyama, Y Ando… - Clinical and …, 2024 - Springer
Background Burn patients often face a high risk of acute kidney injury (AKI) after severe burn
injuries, meanwhile epigallocatechin-3-gallate (EGCG) has been proven to be effective in …

Impact of immune‐related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

K Suzuki, Y Yasui, K Tsuchiya… - Journal of …, 2024 - Wiley Online Library
Abstract Background and Aim Immune checkpoint inhibitors pose the risk of immune‐related
adverse events (irAEs). Recent data suggest that irAEs may be associated with a favorable …

Endocrine Immune-Related Adverse Events Are Independent Predictors of Survival in Patients with Lung Cancer

E Panagiotou, S Ntouraki, IA Vathiotis, ME Livanou… - Cancers, 2024 - mdpi.com
Simple Summary Lung cancer is a global health concern, but survival rates have improved
due to novel treatments, including immunotherapy. Treatment with immune checkpoint …

Preoperative stereotactic radiosurgery for cerebral metastases: safe, effective, and decreases steroid dependency

AN Mallela, UK Iheagwara, D Fogg, A Anthony… - Journal of …, 2024 - thejns.org
OBJECTIVE Preoperative stereotactic radiosurgery (SRS) is emerging as a viable
alternative to standard postoperative SRS. Studies have suggested that preoperative SRS …

Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society

N Collongues, F Durand-Dubief… - Multiple Sclerosis …, 2024 - journals.sagepub.com
Background: Epidemiological data reveal that 45% of persons with multiple sclerosis
(PwMS) in France are more than 50 years. This population more than 50 is more susceptible …

[HTML][HTML] Correlation between immune-related adverse events and efficacy of PD-(L) 1 inhibitors in small cell lung cancer: a multi-center retrospective study

J Zhang, A Gao, S Wang, Y Sun… - Respiratory …, 2024 - respiratory-research.biomedcentral …
Patients receiving PD-(L) 1 inhibitors frequently encounter unusual side effects known as
immune-related adverse events (irAEs). However, the correlation of irAEs development with …

Glucocorticoids in Lung Cancer: Navigating the Balance Between Immunosuppression and Therapeutic Efficacy

W Xu, J Ye, Z Cao, Y Zhao, Y Zhu, L Li - Heliyon, 2024 - cell.com
Glucocorticoids (GCs), a class of hormones secreted by the adrenal glands, are released
into the bloodstream to maintain homeostasis and modulate responses to various stressors …